These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8481024)

  • 1. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.
    Viskochil DH
    J Clin Invest; 2003 Dec; 112(12):1791-3. PubMed ID: 14679174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketotifen inhibits urticaria and tumor progression in neurofibromatosis].
    Haustein UF
    Dermatol Monatsschr; 1989; 175(9):581-4. PubMed ID: 2511044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketotifen and neurofibromatosis.
    Krause L
    Arch Dermatol; 1988 May; 124(5):651-2. PubMed ID: 2452604
    [No Abstract]   [Full Text] [Related]  

  • 4. Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.
    Riccardi VM
    Arch Dermatol; 1987 Aug; 123(8):1011-6. PubMed ID: 3115189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin therapy for uremic pruritus.
    Tercedor J; López-Hernández B; Ródenas JM; Herranz MT; Serrano-Ortega S
    N Engl J Med; 1992 Sep; 327(10):734; author reply 734-5. PubMed ID: 1495538
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of neurofibromatosis 1 with ketotifen. A report of three cases.
    Rodriguez-Jimenez P; Chicharro P; Muñoz E; Dauden E
    Am J Med Genet A; 2016 Apr; 170A(4):1092-4. PubMed ID: 26738422
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy for neurofibromatosis?
    Meyer LJ
    Arch Dermatol; 1993 May; 129(5):625-6. PubMed ID: 8481024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ketotifen (Zaditen and K-Asthmal): a drug with sales disproportionate to its demonstrated effectiveness].
    Pérez-Padilla JR
    Gac Med Mex; 1999; 135(2):165-70. PubMed ID: 10327750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pruritus. Physiology, pathophysiology, clinical aspects and therapy].
    Heyer G
    Med Monatsschr Pharm; 1995 Nov; 18(11):320-9. PubMed ID: 8544789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pruritus. Causes and treatment possibilities].
    Schubert-Sollberg E; Sollberg S
    Med Monatsschr Pharm; 1998 Aug; 21(8):230-5. PubMed ID: 9729674
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating pruritus. What's new in safe relief of symptoms?
    Millikan LE
    Postgrad Med; 1996 Jan; 99(1):173-6, 179-84. PubMed ID: 8539203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical anti-itch therapy.
    Hercogová J
    Dermatol Ther; 2005; 18(4):341-3. PubMed ID: 16297007
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.